Establishment of the Human Intestinal and Salivary Microbiota Biobank - Oncologic Diseases
NCT04698161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-08-04
Summary
This is a prospective, clinical, multicentre study aimed to collect biological samples and study microbiota from subjects with non-small-cell lung cancer (NSCLC) and metastatic melanoma. Microbiota is a complex consortium of microorganisms, located at the mucosal level (in particular intestinal, oral and vaginal) having a key role in human health and in the onset of several diseases. Microbiota alterations have been found in several diseases (gastrointestinal, metabolic, renal, oncological, gynaecological)
The study will allow to:
* Provide biological samples (faeces, saliva, blood, urine) from oncologic patients to the first Italian microbiota biobank;
* Study microorganisms using different in vitro and in vivo techniques;
* Study the link between the microbiota and the disease. This study is part of the BIOMIS project (Project Code: ARS01\_01220), presented as part of the "Avviso per la presentazione di progetti di ricerca industriale e sviluppo sperimentale nelle 12 aree di specializzazione individuate dal PNR 2015-2020" and admitted to funding under the National Operational Program "Ricerca e Innovazione" 2014-2020 by directorial decree of MIUR - Department for Higher Education and Research - n. 2298 of 12 September 2018. BIOMIS includes several clinical studies that enrol patients with different pathologies to collect and store biological samples and study microbiota.
Conditions
- Non Small Cell Lung Cancer
- Metastatic Melanoma
Interventions
- OTHER
-
Biological sample collection
Collection of faeces, coproculture examination, urine, saliva, PBMC and blood for biobanking, to evaluate the proteomic, metascriptomic, metabolomic, metagenomic, and metagenetic profile, and to perform routine screening. Analysis for the identification, quantification and characterization of health-promoting bacteria
- OTHER
-
Questionnaire
Anamnestic questionnaire, 3-day food questionnaire, Food Frequency Questionnaire
- OTHER
-
Medical examination
Blood pressure measurement, abdominal and thoracic physical examination
Sponsors & Collaborators
-
Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies
collaborator OTHER -
Istituti Tumori Giovanni Paolo II
collaborator NETWORK -
University of Bari Aldo Moro
collaborator OTHER -
University of Salento
collaborator OTHER -
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
lead OTHER
Principal Investigators
-
Angelo V Paradiso, MD · IRCCS Istituto Tumori Giovanni Paolo II
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-25
- Primary Completion
- 2022-07-11
- Completion
- 2022-07-11
Countries
- Italy
Study Locations
More Related Trials
-
"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.
NCT05818865 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
NCT00898781 ·Status: TERMINATED
-
Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer
NCT06800469 ·Status: RECRUITING ·Phase: NA
-
Prediction of True Oligo-metastatic Disease.
NCT05806151 ·Status: RECRUITING
-
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance
NCT06653127 ·Status: RECRUITING
-
Analysis of Circulating Tumor Markers in Blood
NCT04025541 ·Status: RECRUITING ·Phase: NA
-
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
NCT00898183 ·Status: COMPLETED
-
Microbiome in Head and Neck Squamous Cell Carcinoma
NCT05837221 ·Status: RECRUITING
-
Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy
NCT02133222 ·Status: COMPLETED ·Phase: NA
-
Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors
NCT05831631 ·Status: RECRUITING
-
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
NCT06036563 ·Status: RECRUITING
-
Liquid Micro-biopsy: a Novel Approach to Study Tumor Microenvironment From the Peripheral Blood
NCT06764589 ·Status: ACTIVE_NOT_RECRUITING
-
Role of Gut Microbiome in Cancer Therapy
NCT05112614 ·Status: RECRUITING
-
Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma
NCT06863870 ·Status: ACTIVE_NOT_RECRUITING
-
Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
NCT04298892 ·Status: UNKNOWN
-
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
NCT01563861 ·Status: COMPLETED
-
Mutational Oncology in Clinical Practice
NCT06020625 ·Status: RECRUITING ·Phase: NA
-
National Cancer Institute "Cancer Moonshot Biobank"
NCT04314401 ·Status: ACTIVE_NOT_RECRUITING
-
Development of New Methodologies and Innovative Tools for the diagnoSi and Therapeutic Treatment of uMAni Epithelial Tumors
NCT06939049 ·Status: COMPLETED
-
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 ·Status: UNKNOWN
-
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NCT04456972 ·Status: COMPLETED ·Phase: NA
-
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
NCT01031056 ·Status: WITHDRAWN
-
Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA
NCT06606366 ·Status: RECRUITING ·Phase: NA
-
Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis
NCT01268956 ·Status: UNKNOWN
-
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
NCT05819827 ·Status: TERMINATED